MPOX has the potential to become a significant global threat if international action isn’t taken now, warn scientists. Mpox ...

After hearing from African leaders and getting their buy-in, public health leaders agreed on a three-part plan to address the ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

A collaborative research effort between the A*STAR Infectious Diseases Labs (A*STAR IDL) and the A*STAR Institute of High ...

Sex workers have been twice victimised, first by the virus and then by the stigma, but advocates hope the government will ...

A study by A*STAR Infectious Diseases Labs (A*STAR IDL) and A*STAR Institute of High Performance Computing (A*STAR IHPC) has assessed the airborne transmission risk of mpox compared to SARS-CoV-2 and ...

After a review of evidence, the UK Health Security Agency (HSA) said today that it no longer classifies clade 1a and 1b mpox ...

New data on Mpox vaccine effectiveness Date: March 19, 2025 Source: Charité - Universitätsmedizin Berlin Summary: A study has found that a single dose of the Imvanex vaccine provides protection ...

Mpox was perceived to be a mild disease which had implications on the study population’s behavioural practices affecting ...

The UK Health Security Agency has developed a toolkit to guide research and preparedness efforts in biosecurity.